Alkermes plc.

Ownership Transactions Reported by 23 Insiders

Symbol
ALKS on Nasdaq
Industry
Pharmaceutical Preparations
Location
Connaught House, 1 Burlington Road, Dublin 4, Ireland

Insiders trading volume in the past year

Alkermes plc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard F. Pops Director and CEO, Alkermes plc, Director $47.9M Feb 19, 2025
Michael J. Landine SVP, Corp Dev., Alkermes, Inc. $10.1M Feb 23, 2024
David Joseph Gaffin EVP, CLO, Alkermes, Inc. $7.11M Feb 26, 2025
Blair C. Jackson EVP, Chief Operating Officer $7.01M Feb 26, 2025
Iain M. Brown SVP, Chief Financial Officer $5.16M Feb 26, 2025
Christian Todd Nichols SVP, Chief Commercial Officer $3.23M -$152K -4.49% Feb 26, 2025
David Angelo Daglio Jr. Director $3.13M Jun 29, 2024
Shane Cooke Director $2.95M Jun 29, 2024
Craig C. Hopkinson EVP R&D, Chief Medical Officer $2.7M -$19.9M -88% Feb 26, 2025
David W. Anstice Director $2.2M Jun 14, 2022
Wendy L. Dixon Director $1.86M Jun 14, 2022
Brian P. Mckeon Director $1.45M Jun 29, 2024
Cato T. Laurencin Director $1.27M -$85.7K -6.32% Dec 8, 2024
Nancy Wysenski Director $1.21M Jul 7, 2023
Emily Peterson Alva Director $1.2M Jun 29, 2024
nancy lynn snyderman MD Director $1.15M Jun 29, 2024
Frank A. Wilson Director $1.14M Jun 29, 2024
Richard Gaynor Director $1.14M Jun 29, 2024
Christopher I. Wright Director $885K Jun 29, 2024
Nancy Lurker Director $662K Apr 11, 2025
Paul J. Mitchell Director $470K May 20, 2021
Robert A. Breyer Director $267K May 20, 2021
Samuel Joseph Parisi VP, Finance (Interim PAO) $262K -$245K -48.3% Feb 26, 2025

Recent Insider Transactions by Companies or Individuals for Alkermes plc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.